Prophylactic metformin after antenatal corticosteroids (PROMAC): a double blind randomized controlled trial

BACKGROUND: Antenatal corticosteroids (ACS) are increasingly used to improve prematurity-related neonatal outcome. A recognized and common adverse effect from administration of antenatal corticosteroid is maternal hyperglycemia. Even normal pregnancy is characterized by relative insulin resistance a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Jesrine Gek Shan, Tan, Peng Chiong, Kamarudin, Maherah, Omar, Siti Zawiah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885598/
https://www.ncbi.nlm.nih.gov/pubmed/33588801
http://dx.doi.org/10.1186/s12884-021-03628-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885598/
https://www.ncbi.nlm.nih.gov/pubmed/33588801
http://dx.doi.org/10.1186/s12884-021-03628-5

Ejemplares similares